Maria Themeli

10PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 21, 2026
CAR T cell-derived TNF is an early determinant of cytokine release syndrome severity.

|Apr 14, 2026
T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

Francesca Marzuttini, Alessia Potenza, Ludovica Celli

|Jul 26, 2024
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.

Charlotte L B M Korst, Chloe O'Neill, Wassilis S C Bruins

|Aug 01, 2023
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138.

Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel

|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.

Emmanuel Donnadieu, Maik Luu, Miriam Alb

|Dec 08, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik

Pageof 2

Frequent Collaborators

3 joint publications

Sonja Zweegman

2 joint publications

Richard W J Groen

2 joint publications

Afroditi Katsarou

2 joint publications

Michel Sadelain